Skip to content
Back to Blog
Bio
2026-04-137 min read55

2026 Pre-GMP Evaluation Document Simplification and Raw Material Certification Pilot — Practical Guide for Bio SMEs

Korea's MFDS is simplifying pre-GMP evaluation from 11 to 4 document types and launching a raw material certification pilot in 2026. Here's what bio SMEs need to know for practical compliance.

KITIM Consulting Team

Key Changes in MFDS GMP Regulatory Reform for 2026

In 2026, Korea's Ministry of Food and Drug Safety (MFDS) is dramatically simplifying pre-GMP evaluation documentation and launching a raw material manufacturing site certification pilot. For bio SMEs, this opens a dual opportunity: reduced regulatory costs and stronger export competitiveness.

Pre-GMP Submission Documents: From 11 to 4

Previously, pre-GMP evaluation required 11 separate document types, including facility overviews, hygiene standards, quality control manuals, manufacturing control manuals, equipment lists, organizational charts, and process validation reports. The 2026 revision consolidates these into 4 documents: a general site overview, an integrated quality and manufacturing management summary, a key validation summary, and a self-inspection report.

  • 3 documents eliminated: organizational charts (merged into site overview), equipment lists (replaced by on-site inspection), and raw material test certificates (separated into raw material certification)
  • 4 documents merged: three separate standards manuals combined into a single integrated summary
  • Expected impact: average preparation time reduced from 6–8 months to 3–4 months, with greater focus on actual manufacturing capability
  • CDMO Special Act and Export Manufacturing Registration

    Subordinate regulations under the CDMO Special Act are set for implementation in the second half of 2026. A new export-only pharmaceutical manufacturing registration system will allow production for export with GMP certification alone, without requiring domestic marketing authorization. Combined with simplified pre-GMP procedures, this significantly lowers market entry barriers for new CDMO companies.

    Strategies for the Raw Material Certification Pilot

    Pilot Scope and Certification Process

    The raw material manufacturing site certification pilot targets domestic facilities producing active pharmaceutical ingredients (APIs) and key intermediates. The process consists of document review (approximately 60 days), on-site inspection (2–3 days), and certificate issuance (valid for 3 years). During the pilot period, certification fees are reduced by 50%.

    Practical Impact on Finished Product Approvals

    When using raw materials from a certified manufacturing site, documentation related to raw materials is waived during finished product approval review. This typically shortens review timelines by 45–60 days on average — a benefit that compounds for companies producing multiple products from the same API source.

    Global GMP Trends and Domestic Alignment

    The European Medicines Agency (EMA) will tighten API GMP requirements starting December 2026, mandating Written Confirmation of GMP compliance for all APIs distributed within the EU. Korea's raw material certification program is expected to serve as a foundation for mutual recognition arrangements with EMA standards.

    Practical Checklist for Bio SMEs

    Writing Tips for the 4 Simplified Documents

  • General site overview: Include organizational structure and personnel details, with specific qualifications and experience of key quality personnel (QA/QC managers)
  • Integrated quality and manufacturing summary: Consolidate essentials from the previous three manuals — common deficiency reasons include *missing deviation management procedures* and *undocumented change control histories*
  • Key validation summary: Must include 3-batch process validation results and cleaning validation summaries
  • Self-inspection report: Include results from inspections conducted within the past year, along with corrective actions for any non-conformities
  • Transition for Companies with Existing GMP Certificates

    Companies with valid GMP certificates will automatically transition to the simplified format at renewal. However, those scheduled for renewal within 2026 should confirm with MFDS in advance whether the new format applies to their submission.

    Leveraging the Bio Raw Materials User Testing Support Program

    The Ministry of Trade, Industry and Energy's Bio Raw Materials User Testing Support Program (2026 budget: KRW 15.6 billion) covers up to 70% of quality verification costs for domestically sourced raw materials. When combined with the raw material certification pilot, companies can significantly reduce costs from quality verification through certification.

    KITIM Consulting — GMP Certification Advisory and Regulatory Support

    KITIM provides end-to-end consulting from GMP documentation preparation to on-site inspection readiness and raw material certification pilot participation strategy. Our practical support includes submission document coaching aligned with the simplified pre-GMP requirements, mock self-inspections, and validation document reviews to maximize your certification success rate. For expert guidance on GMP certification and bio regulatory affairs, please reach out through KITIM Contact Us.

    Pre-GMP EvaluationDocument SimplificationRaw Material CertificationMFDS Regulatory InnovationBio Quality Management

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.